SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-08-034393
Filing Date
2008-05-19
Accepted
2008-05-19 17:26:29
Documents
5
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a08-11850_110q.htm 10-Q 960425
2 EX-10.1 a08-11850_1ex10d1.htm EX-10.1 620325
3 EX-31.1 a08-11850_1ex31d1.htm EX-31.1 13526
4 EX-31.2 a08-11850_1ex31d2.htm EX-31.2 13155
5 EX-32.1 a08-11850_1ex32d1.htm EX-32.1 10085
  Complete submission text file 0001104659-08-034393.txt   1619011
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 08846171
SIC: 2835 In Vitro & In Vivo Diagnostic Substances